Peter Tjeerdsma

Peter Tjeerdsma Email and Phone Number

VP CMC and Regulatory at Synaffix BV @ Synaffix BV
Peter Tjeerdsma's Location
The Randstad, Netherlands, Netherlands, Netherlands
Peter Tjeerdsma's Contact Details

Peter Tjeerdsma work email

Peter Tjeerdsma personal email

About Peter Tjeerdsma

Extensive experience in CMC and Project leadership of complex, international, development programs in the pharmaceutical, biotechnology and food and feed industries. Typical activities include defining the strategy for and the execution of process and analytical development, and clinical batch manufacture; technology transfer across sites; production and testing of comparability and or consistency batches according GMP regulations and their eventual filing with the various authorities (FDA, EMEA, Health Canada etc.).My goal as project leader is always to assure the successful execution, within time and budget, while maintaining core values: Team, Empowerment, Professionalism, Engagement, Working Hard and last but not least Fun.Specialities: Leadership, CMC, Project ManagementTechnology Transfer, New Product IntroductionGMP, Compliance, Failure investigationTeamwork

Peter Tjeerdsma's Current Company Details
Synaffix BV

Synaffix Bv

View
VP CMC and Regulatory at Synaffix BV
Peter Tjeerdsma Work Experience Details
  • Synaffix Bv
    Vp Cmc And Regulatory
    Synaffix Bv Jan 2020 - Present
    Nl
  • Maggres-Pharma
    Cmc Consultant And Owner
    Maggres-Pharma Oct 2017 - Present
  • T3 Pharmaceuticals Ag
    Head Of Cmc
    T3 Pharmaceuticals Ag Jan 2022 - Jun 2024
    Basel, Bs, Ch
  • Staten Biotechnology B.V.
    Director Cmc
    Staten Biotechnology B.V. Oct 2017 - Feb 2023
  • Crucell
    Sr. Cmc-Leader
    Crucell May 2015 - Sep 2017
    May 2015 - Sep 2015: CMC Leader of an early phase development program of a PEGylated Fab (consultation).May 2015 - present: CMC leader of an accelerated late stage development program for a monovalent Ebola vaccine.May 2015 - present: CMC Leader of an early stage development program of a multivalent filovirus vaccine, intended to protect against most common filoviruses including Ebola.
  • Crucell
    Flawless Project Execution Trainer And Coach
    Crucell May 2014 - Sep 2017
    Since September 2013 trainer and coach in the JnJ FPX (flawless project execution) methodology. Implementation co-lead for Crucell.
  • Crucell
    Cmc Leader
    Crucell May 2010 - May 2015
    May 2010 - May 2015 CMC Leader of Anti-Rabies mAb CL184. CL184 is a late clinical stage dual antibody combination intended to provide initial passive immunization against Rabies. Nov 2013 - May 2015 CMC Leader of multivalent filovirus vaccine, an early development stage vaccine to protect against most common filoviruses including Ebola. August 2014 - May 2015 CMC leader of monovalent Ebola vaccine, an accelerated development vaccine to protect against Ebola virus only.Nov 2013 - May 2015 CMC Leader of a PEGylated Fab as part of an early phase development
  • The Janssen Pharmaceutical Companies Of Johnson & Johnson
    Api Technology Owner
    The Janssen Pharmaceutical Companies Of Johnson & Johnson Jan 2010 - Apr 2010
    Raritan, New Jersey, Us
    Technology owner for the active pharmaceutical ingredient of Stelara.
  • The Janssen Pharmaceutical Companies Of Johnson & Johnson
    Project Manager Npi
    The Janssen Pharmaceutical Companies Of Johnson & Johnson Feb 2009 - Apr 2010
    Raritan, New Jersey, Us
    Feb '09 to Apr '10Project manager responsible for the technology transfer of the commercial upstream process Stelara from St. Louis to Leiden.Project manager responsible for the technology transfer of the clinical upstream process CNTO95 from St. Louis to Leiden.
  • The Janssen Pharmaceutical Companies Of Johnson & Johnson
    Associate Project Manager Npi
    The Janssen Pharmaceutical Companies Of Johnson & Johnson Jun 2007 - Jan 2009
    Raritan, New Jersey, Us
    June '07 - March '09Project manager responsible for the technology transfer of the cell culture part of the production proces of CNTO328 from St. Louis to Leiden.April '09 to Jan '09Project manager responsible for the technology transfer of the upstream production proces of CNTO1275 and CNTO95 from St. Louis to Leiden.Both functions involve the management of international, multi-disciplinary and cross-functional project teams to Introduce New Products and technologies in the Leiden site. The technology transfers include the production and testing of comparability and or consistency batches according GMP regulations and their eventual filing with the various authorities (FDA, EMEA, Health Canada etc.).
  • The Janssen Pharmaceutical Companies Of Johnson & Johnson
    Technical Specialist / Technology Transfer
    The Janssen Pharmaceutical Companies Of Johnson & Johnson Jul 2006 - Jun 2007
    Raritan, New Jersey, Us
    -Project manager transfer of ReoPro from P- to M-building-Project manager transfer of CNTO148 from P- to M-building-Supporting activities for the CNTO148 Commercial Manufacturing Program.
  • The Janssen Pharmaceutical Companies Of Johnson & Johnson
    Technical Specialist / Lead Investigator
    The Janssen Pharmaceutical Companies Of Johnson & Johnson Oct 2004 - Jul 2006
    Raritan, New Jersey, Us
    -Troubleshooting using a.o. six sigma and Kepner-trechoe methodology-GMP non-conformance investigation-Project manager transfer of ReoPro from P- to M-building
  • Campina
    Process Technologist
    Campina Oct 2001 - Aug 2004
    Amersfoort, Nl
    Process Technologist in the process development departement. Worked in areas of cGMP, food and feed (HACCP). Activities include:-Process troubleshooting-Process design and modeling-Initiation and execution of process improvement projects-Coordination of cleaning validation of lactose plant, including writing VMP, protocols, execution and reporting of cleaning validations-Participation in HACCP implementation project-Delivering updated SAP BOM recipes for 9 billion liters of milk equivalents

Peter Tjeerdsma Skills

Technology Transfer Gmp Biotechnology Fda Manufacturing V&v Biopharmaceuticals Six Sigma Product Development Project Management Pharmaceutical Industry Validation Cleaning Validation Cross Functional Team Leadership Life Sciences R&d Sop

Peter Tjeerdsma Education Details

  • Delft University Of Technology
    Delft University Of Technology
    Bioprocess Design
  • Wageningen University & Research
    Wageningen University & Research
    Bioprocesstechnology
  • Melanchthon College Rotterdam
    Melanchthon College Rotterdam
    High School

Frequently Asked Questions about Peter Tjeerdsma

What company does Peter Tjeerdsma work for?

Peter Tjeerdsma works for Synaffix Bv

What is Peter Tjeerdsma's role at the current company?

Peter Tjeerdsma's current role is VP CMC and Regulatory at Synaffix BV.

What is Peter Tjeerdsma's email address?

Peter Tjeerdsma's email address is pe****@****ell.com

What schools did Peter Tjeerdsma attend?

Peter Tjeerdsma attended Delft University Of Technology, Wageningen University & Research, Melanchthon College Rotterdam.

What skills is Peter Tjeerdsma known for?

Peter Tjeerdsma has skills like Technology Transfer, Gmp, Biotechnology, Fda, Manufacturing, V&v, Biopharmaceuticals, Six Sigma, Product Development, Project Management, Pharmaceutical Industry, Validation.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.